Computing and Library Services - delivering an inspiring information environment

Items where Author is Airley, Rachel

Up a level
Export as [feed] RSS
Jump to: 2014 | 2013 | 2012 | 2011 | 2010 | 2008 | 2007 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000
Number of items: 26.


Hemming, Karl, Chambers, Christopher Steven, Hamasharif, Muslih S., Joãoa, Heidi, Khan, Musharraf N., Patel, Nilesh, Airley, Rachel and Day, Sharn (2014) Azide based routes to tetrazolo and oxadiazolo derivatives of pyrrolobenzodiazepines and pyrrolobenzothiadiazepines. Tetrahedron, 70 (40). pp. 7306-7317. ISSN 0040-4020

Airley, Rachel, McHugh, Patrick C, Evans, A.R., Harris, B., Winchester, L., Buffa, F.M., Al-Tameemi, W., Leek, R. and Harris, Adrian L. (2014) Role of carbohydrate response element-binding protein (ChREBP) in generating an aerobic metabolic phenotype and in breast cancer progression. British Journal of Cancer, 110. pp. 715-723. ISSN 0007-0920


Bishop, Emily, Yusuf, Alex, Stephenson, John and Airley, Rachel (2013) A metabolic phenotype in sarcoma? Repression of skeletal muscle transcription factor mondo A (Mlx- Interacting Protein). In: 2nd International Conference on Tumor Microenvironment and Cellular Stress: Signaling, Metabolism, Imaging and Therapeutic Targets, September 27-October 2, 2013, Corfu, Greece. (Unpublished)


Airley, Rachel, Buckle, S. and Hadley, S. (2012) Supply and demand: How do we ensure a bright future for all pharmacists? Pharmaceutical journal, 289 (7734). pp. 636-637. ISSN 0031-6873

Airley, Rachel and Evans, Andy (2012) How the science of personalized medicines will change the clinical management of patients in the pharmacy. Future Medicinal Chemistry, 4 (16). pp. 2023-2027. ISSN 1756-8919

Airley, Rachel (2012) Lab reports and cat scans: can veterinary oncology guide our way to new treatments for human cancers? Future Medicinal Chemistry, 4 (11). pp. 1391-1394. ISSN 1756-8919

Airley, Rachel (2012) Pharmacists are boring but important; what can we do to improve our image? Pharmaceutical journal, 288 (7698). pp. 391-392. ISSN 0031-6873


Airley, Rachel (2011) Hypothesis-driven, mechanism-led: There's an inner scientist in all of us. Pharmaceutical journal, 286 (7674). pp. 433-434. ISSN 0031-6873

Golinska, Monika, Troy, Helen, Chung, Yuen-Li, McSheehy, Paul M., Mayr, Manuel, Yin, Xiaoke, Ly, Lucy, Williams, Kaye J., Airley, Rachel E., Harris, Adrian L., Latigo, John, Perumal, Meg, Aboagye, Eric O., Perrett, David, Stubbs, Marion and Griffiths, John R. (2011) Adaptation to HIF-1 deficiency by upregulation of the AMP/ATP ratio and phosphofructokinase activation in hepatomas. BMC Cancer, 11 (1). pp. 198-211. ISSN 1471-2407


Airley, Rachel (2010) Traditionalist, idealist or realist: Where are you in the evolution of pharmacy? Pharmaceutical journal, 285 (7617). pp. 242-243. ISSN 0031-6873

Airley, Rachel, Evans, Andrew, Mobasheri, Ali and Hewitt, Stephen M. (2010) Glucose transporter Glut-1 is detectable in peri-necrotic regions in many human tumor types but not normal tissues: Study using tissue microarrays. Annals of Anatomy - Anatomischer Anzeiger, 192 (3). pp. 133-138. ISSN 0940-9602

Airley, Rachel (2010) Pharmacists as survivors - What role could we have after an apocalypse? Pharmaceutical journal, 284 (7859). pp. 163-164. ISSN 0031-6873


Charnley, N., Airley, Rachel, Du Plessis, D., West, Catharine M.L., Brock, C., Barnett, C., Matthews, J., Symonds, K., Bottomly, M., Swindell, R. and Price, P. (2008) No relationship between 18F-fluorodeoxyglucose positron emission tomography and expression of Glut-1 and -3 and hexokinase I and II in high-grade glioma. Oncology Reports, 20 (3). pp. 537-542. ISSN 1021-335X

Evans, Andrew, Bates, Victoria, Troy, Helen, Hewitt, Stephen M., Holbeck, Susan, Chung, Yuen-Li, Phillips, Roger, Stubbs, Marion, Griffiths, John and Airley, Rachel (2008) Glut-1 as a therapeutic target: increased chemoresistance and HIF-1-independent link with cell turnover is revealed through COMPARE analysis and metabolomic studies. Cancer Chemotherapy and Pharmacology, 61 (3). pp. 377-393. ISSN 0344-5704


Airley, Rachel and Mobasheri, Ali (2007) Hypoxic Regulation of Glucose Transport, Anaerobic Metabolism and Angiogenesis in Cancer: Novel Pathways and Targets for Anticancer Therapeutics. Chemotherapy, 53 (4). pp. 233-256. ISSN 0009-3157


Airley, Rachel, Phillips, Roger M., Evans, A.E., Double, J.A., Burger, A.M., Feibig, H.H., West, Catharine M.L. and Stratford, I.J. (2005) Hypoxia-regulated glucose transporter Glut-1 may influence chemosensitivity to some alkylating agents: results of EORTC (First Translational Award) study of the relevance of tumour hypoxia to the outcome of chemotherapy in human tumour-derived xenografts. International journal of oncology, 26 (6). pp. 1477-1484. ISSN 1019-6439

Mobasheri, A., Airley, Rachel, Hewitt, Stephen M. and Marples, D. (2005) Heterogeneous expression of the aquaporin 1 (AQP1) water channel in tumors of the prostate, breast, ovary, colon and lung: a study using high density multiple human tumor tissue microarrays. International journal of oncology, 26 (5). pp. 1149-1158. ISSN 1019-6439


Oliver, R, Woodwards, R T M, Sloan, P, Thakker, N S, Stratford, I J and Airley, Rachel (2004) Prognostic value of facilitative glucose transporter Glut-1 in oral squamous cell carcinomas treated by surgical resection results of EORTC Translational Research Fund studies. European Journal of Cancer, 40 (4). pp. 503-507. ISSN 0959-8049

Mobasheri, A., Airley, Rachel, Foster, C.S., Schulze-Tanzil, G. and Shakibaei, M. (2004) Post-genomic applications of tissue microarrays: basic research, prognostic oncology, clinical genomics and drug discovery. Histology and Histopathology, 19 (1). pp. 325-335. ISSN 0213-3911


Cooper, R, Sarioğlu, S, Sökmen, S, Füzün, M, Küpelioğlu, A, Valentine, H, Görken, I B, Airley, Rachel and West, Catharine M.L. (2003) Glucose transporter-1 (GLUT-1): a potential marker of prognosis in rectal carcinoma? British Journal of Cancer, 89 (5). pp. 870-876. ISSN 0007-0920

Cowen, Rachel L., Patterson, Adam V., Telfer, Brian A. and Airley, Rachel (2003) Viral delivery of P450 reductase recapitulates the ability of constitutive overexpression of reductase enzymes to potentiate the activity of mitomycin C in human breast cancer xenografts. Molecular Cancer Therapeutics, 2 (9). pp. 901-909. ISSN 1535-7163

Airley, Rachel, Loncaster, Juliette, Raleigh, James A., Harris, Adrian L., Davidson, Susan E., Hunter, Robert D., West, Catharine M.L. and Stratford, Ian J. (2003) GLUT-1 and CAIX as intrinsic markers of hypoxia in carcinoma of the cervix: Relationship to pimonidazole binding. International Journal of Cancer, 104 (1). pp. 85-91. ISSN 0020-7136


Patterson, Adam V., Williams, Kaye J, Cowen, Rachel L., Jaffar, M, Telfer, B A, Saunders, M, Airley, Rachel, Honess, D, Van der Kogel, A J, Wolf, C R and Stratford, I J (2002) Oxygen-sensitive enzyme-prodrug gene therapy for the eradication of radiation-resistant solid tumours. Gene Therapy, 9 (14). pp. 946-954. ISSN 0969-7128

Williams, Kaye J, Telfer, Brian A, Airley, Rachel, Peters, Hans PW, Sheridan, Mary R, van der Kogel, Albert J, Harris, Adrian L. and Stratford, Ian J (2002) A protective role for HIF-1 in response to redox manipulation and glucose deprivation: implications for tumorigenesis. Oncogene, 21 (2). pp. 282-290. ISSN 0950-9232


Airley, Rachel, Loncaster, Juliette, Davidson, Susan, Bromley, Mike, Roberts, Stephen, Patterson, Adam V., Hunter, Robin, Stratford, Ian and West, Catharine M.L. (2001) Glucose transporter Glut-1 expression correlates with tumor hypoxia and predicts metastasis-free survival in advanced carcinoma of the cervix. Clinical cancer research, 7 (4). pp. 928-934. ISSN 1078-0432


Airley, Rachel and Monaghan, Jane E (2000) Hypoxia and disease: opportunities for novel diagnostic and therapeutic prodrug strategies. Pharmaceutical journal, 264 (7094). pp. 666-673. ISSN 0031-6873

This list was generated on Wed Sep 28 18:18:59 2022 UTC.

University of Huddersfield, Queensgate, Huddersfield, HD1 3DH Copyright and Disclaimer All rights reserved ©